The present invention relates to a kit and an in vitro method for detecting and characterizing the degradation of a particular organ or tissue, on the basis of the analysis of the presence of at least one specific methylated cell-free DNA in a biological sample.
CGenetix develops the new generation of liquid biopsy biomarkers to evaluate organs damages during a pathological process.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet, consectetur adipiscing elit ut elit tellus.
Lorem ipsum dolor sit amet, consectetur adipiscing elit ut elit tellus.
Lorem ipsum dolor sit amet, consectetur adipiscing elit ut elit tellus.